✦ LIBER ✦

Experience in the Use of the Anticonvulsant Pregabalin as an Add-On Therapy in Patients with Partial Epilepsy with Polymorphic Seizures

✍ Scribed by I. I. Bondarenko

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 65 KB
Volume: 40
Category: Article
ISSN: 0097-0549
DOI: 10.1007/s11055-009-9242-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term observations on the clinical u

Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy

✍ Leonardo Cocito; Maura Maffini; Carlo Loeb 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 373 KB

A double-blind, placebo-controlled evalu

A double-blind, placebo-controlled evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures

✍ T Rentmeester; A Janssen; J Hulsman; F Scholtes; B van der Kleij; J Overweg; J M 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 655 KB

Sixty-two patients with uncontrolled partial seizures participated in a 12-week, double-blind, placebo-controlled add-on-trial. Thirty-two patients received loreclezole and 30 a placebo as add-on therapy. Loreclezole was targeted at a plasma level of 1-2 mg/l. In spite of an antiepileptic therapy, u

Long-term evaluation of the efficacy and

Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-up

✍ T. Rentmeester; A. Janssen; J. Hulsman; F. Scholtes; B. van der Kleij; J. Overwe 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 534 KB

The effect and safety of loreclezole were evaluated during a long-term follow-up trial targeting higher plasma concentrations than those of the preceding controlled trial. The result is better than in the double-blind trial, in which loreclezole doses were administered to reach plasma concentrations

Use of a new antioxidant diquertin as an

Use of a new antioxidant diquertin as an adjuvant in the therapy of patients with acute pneumonia

✍ V. K. Kolhir; V. A. Bykov; Yu. O. Teselkin; I. V. Babenkova; N. A. Tjukavkina; I 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 2 views

A clinical investigation was conducted of therapy of patients with acute pneumonia using a new antioxidant diquertin, whose primary component is a bioflavonoid, dihydroquercetin. It was demonstrated that patients with acute pneumonia receiving diquertin in an adjuvant therapy had a faster recovery f

Initial experience with the use of an ex

Initial experience with the use of an expandable titanium cage as a vertebral body replacement in patients with tumors of the spinal column: a report of 95 patients

✍ Ashwin Viswanathan; Muhammad M. Abd-El-Barr; Egon Doppenberg; Dima Suki; Ziya Go 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 356 KB

The use of plasmapheresis, lymphocytaphe

The use of plasmapheresis, lymphocytapheresis, and staph protein-A immunoadsorption as an immunomodulatory therapy in patients with aids and aids-related conditions

✍ Dobri D. Kiprov; Randolph Lippert; Robert G. Miller; Erik Sandstrom; Frank R. Jo 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

Circulating immune complexes, autodntibodies, and suppressor factors to normal lymphoproliferation may play an important role in the induction and maintenance of the cellular immunodeficiency characteristic for the acquired immunodeficiency syndrome (AIDS) and its related conditions. In order to exp